Sarah Eichenberg

Sarah Eichenberg is the Director of Medical Writing at Jazz Pharmaceuticals where she provides strategic leadership across sleep and hematology oncology therapeutic areas. Sarah has been in the biopharmaceutical industry for over 10 years with experience across a vast array of global submission filings and disease indications.  She has led global transparency and disclosure activities including initial disclosures and registrations of clinical trial data across multiple organizations including EMA’s Policy 0070.

Prior to her time in industry, Sarah worked as an oncology research scientist including a fellowship at the National Institutes of Health Genome Research Institute.  She holds a Master’s degree in Molecular, Cellular, and Development Biology from the University of Michigan and is very active in the pharmaceutical professional network.